ANNAPOLIS, MD — As the federal government prepares to finalize the COVID-19 vaccination strategy for the 2026–2027...
Lina Hope
In the high-stakes world of pharmaceutical development, few therapeutic areas are as crowded yet as persistently underserved...
In the landscape of cancer survivorship, the conversation is shifting from strictly clinical interventions to the proactive...
A groundbreaking Phase II/III clinical trial has unveiled compelling data for a novel therapeutic combination, darovasertib and...
The pharmaceutical industry is currently gripped by a high-stakes "gold rush" centered on a new class of...
Massachusetts-based medical technology innovator CereVasc has successfully closed a significant $85 million Series C financing round, marking...
In the landscape of modern medicine, the humble skin wound is often underestimated. While a minor scrape...
In a fiscal landscape defined by rapid technological shifts and increasing demand for advanced medical intervention, Medtronic...
A groundbreaking study published in the November issue of Plastic and Reconstructive Surgery—the official medical journal of...
Editorial Note: This resource was originally published on February 24, 2025, and has been updated to reflect...
